Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Atypical Presentation of Gelsolin Amyloidosis in a Man of African Descent with a Novel Mutation in the Gelsolin Gene.

Oregel KZ, Shouse GP, Oster C, Martinez F, Wang J, Rosenzweig M, Deisch JK, Chen CS, Nagaraj G.

Am J Case Rep. 2018 Mar 30;19:374-381.

2.

Aberrant splicing and drug resistance in AML.

de Necochea-Campion R, Shouse GP, Zhou Q, Mirshahidi S, Chen CS.

J Hematol Oncol. 2016 Sep 10;9(1):85. doi: 10.1186/s13045-016-0315-9. Review.

3.

B56γ tumor-associated mutations provide new mechanisms for B56γ-PP2A tumor suppressor activity.

Nobumori Y, Shouse GP, Wu Y, Lee KJ, Shen B, Liu X.

Mol Cancer Res. 2013 Sep;11(9):995-1003. doi: 10.1158/1541-7786.MCR-12-0633. Epub 2013 May 30.

4.

HEAT repeat 1 motif is required for B56γ-containing protein phosphatase 2A (B56γ-PP2A) holoenzyme assembly and tumor-suppressive function.

Nobumori Y, Shouse GP, Fan L, Liu X.

J Biol Chem. 2012 Mar 30;287(14):11030-6. doi: 10.1074/jbc.M111.334094. Epub 2012 Feb 7.

5.

ATM-mediated phosphorylation activates the tumor-suppressive function of B56γ-PP2A.

Shouse GP, Nobumori Y, Panowicz MJ, Liu X.

Oncogene. 2011 Sep 1;30(35):3755-65. doi: 10.1038/onc.2011.95. Epub 2011 Apr 4.

PMID:
21460856
6.

A B56gamma mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A.

Shouse GP, Nobumori Y, Liu X.

Oncogene. 2010 Jul 8;29(27):3933-41. doi: 10.1038/onc.2010.161. Epub 2010 May 17.

8.

Supplemental Content

Loading ...
Support Center